Approach is very different from the other clinics.
We are using immune therapy in our bodies when possible. Lack of popularity in the body's immune therapy Oncology show more of the road usually does not work.
For all drugs, including cancer, only after a clinical trial to follow strict guidelines set by regulatory agencies such as FDA.
Until now most of the mandate of the immune therapy will be tested only after failure of conventional chemotherapy.
At present this patient who suffered serious depression, a result of the second cancer.
Conditions like this is extraordinary, immune therapy can be used as the first line treatment, before chemotherapy, radiation, and also some of the operation, which menampilakan face is more active. Read More
No comments:
Post a Comment